Navigation Links
Houston-Based Tyrell, Inc. Completes $28 Million Private Equity Financing

HOUSTON, July 11 /PRNewswire/ -- Tyrell, Inc., the creators of Zeno, an innovative hand-held medical device used in the treatment of acne, today announced that the company has closed a $28 million round of equity financing. The investment was led by Sante Ventures and Catterton Partners, and joined by existing investor Austin Ventures. Tyrell will use the funds to support expanded distribution of the Zeno line as well as to support new product introductions.

Kevin Lalande, Managing Partner for Sante Ventures and Michael Farello, partner at Catterton Partners will join the company's Board of Directors.

"Tyrell has developed a plan to develop consumer products around their proprietary ClearPoint technology in various product categories," said Mr. Lalande. "They have achieved category leadership in Acne Care and are poised to repeat that success in other skin care segments. We at Sante Ventures have followed this company since inception and we are pleased to have the opportunity to become an investment partner."

"Tyrell has built both a brand and a product line which provides a platform for growth," said Mr. Farello. "By focusing on increasing retail velocity and new product introductions, Tyrell is poised to become a major player in the emerging Personal Medical Device category and in personal care more broadly."

Blaine Wesner, General Partner at Austin Ventures will continue as a member of the company's Board of Directors. He noted:

"We continue to be very impressed with the management team at Tyrell as well as the innovative technology being commercialized in the Zeno product line."

Walter Klemp, President and CEO of Tyrell, closed by saying, "The founders of Sante Ventures have broad healthcare investment experience and we are honored that they have chosen to lead this financing round. Catterton Partners brings a breadth of investment expertise in the consumer industry making them an ideal investment partner at our current stage. The addition of these two very experienced investment firms to our highly regarded original investment partners is testament to the progress achieved by the company and the unique investment opportunity Tyrell represents."

About Tyrell, Inc. and Zeno(R)

Established in Houston, Texas, in September 2002, Tyrell, Inc. is the leading pioneer in the category of personal medical devices. The company was formed to develop and launch Zeno, a product set to revolutionize over-the-counter treatment of acne pimples. Utilizing proprietary ClearPoint technology, Zeno electronic medical devices apply sustained heat therapy to destroy the bacteria that causes common acne, dramatically reducing the healing time of pimples. The Zeno acne product line includes Zeno MD, Zeno PRO, Zeno and Zeno Mini. For more information, visit

About Sante Ventures

Sante Ventures is a specialized venture capital firm founded in 2006 by a group of partners with deep healthcare investment and operations experience. In addition to capital, the firm provides its portfolio executives with additional healthcare domain expertise, an extensive network of relationships and singular industry focus. Sante invests exclusively in early-stage companies developing innovative new medical technologies and healthcare services. For more information, please visit

About Catterton Partners

With more than $2.3 billion under management, Catterton Partners is a leading private equity firm in the U.S. focused exclusively on the consumer industry. Since its founding in 1990, Catterton has leveraged its investment capital, strategic and operating skills, and network of industry contacts to establish one of the strongest investment track records in the consumer industry. Catterton invests in all major consumer segments, including food and beverage, retail and restaurants, consumer products and services, and media and marketing services. Catterton has led investments in companies such as Wellness Pet Food, The Worth Collection, Build-A-Bear Workshop, P.F. Chang's China Bistro, Fekkai and Kettle Foods. More information about the firm can be found at

About Austin Ventures

Austin Ventures, with $3 billion dollars under management across nine funds, has provided startup and growth capital to emerging companies for over twenty years. We partner with exceptionally talented entrepreneurs and operating executives to build valuable businesses in a variety of technology and service industries. We invest nationally but maintain a particular focus on Texas, where we are the region's most active investor. Our team of investment professionals works with companies at every stage of the funding lifecycle, from initial seed investments, through startup and growth capital, to management-led buyouts and recapitalizations. Austin Ventures brings a long-term investment perspective, broad experience in building high-growth companies, and access to an unparalleled network of entrepreneurs and executives. Visit for more information.

SOURCE Tyrell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Houston-Based LifeGift Becomes States Only Stand-Alone Organ and Tissue Recovery Agency
2. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
3. Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs
4. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
5. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
6. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
7. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
8. Beeston completes drilling on Bluff Lake property, 100 Mile House
9. PreMD Successfully Completes Project for Health & Beauty Company
10. Sinexus Welcomes New CEO and Completes Series B
11. ACTS Retirement-Life Communities Completes Carlton Cove Acquisition
Post Your Comments:
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Beddit® has ... Beddit Classic sleep tracking systems. The new app features a more intuitive SleepScore™ that ... understand how well you slept. The SleepScore is created by a proprietary algorithm. Beddit ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted ... in Chicago, IL, UV Angel is evaluating the efficacy of its product and its ... units (totaling 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Today, Mothers Against Drunk Driving ... has dropped below 10,000 for the first time since 2011. In 2014, there were ... to data released by the National Highway Traffic Safety Administration (NHTSA), 32,675 people were ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: